Cargando…

Impact of Sacubitril/Valsartan on the Long-Term Incidence of Ventricular Arrhythmias in Chronic Heart Failure Patients

Background: Sacubitril/valsartan decreased the risk of sudden cardiac death (SCD) in patients suffering from heart failure with reduced ejection fraction (HFrEF). However, long-term data are sparse. Objective: The aim of the present study was to compare the incidence of life-threatening arrhythmias...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Battrawy, Ibrahim, Pilsinger, Christina, Liebe, Volker, Lang, Siegfried, Kuschyk, Jürgen, Zhou, Xiaobo, Borggrefe, Martin, Röger, Susanne, Akin, Ibrahim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832713/ https://www.ncbi.nlm.nih.gov/pubmed/31581623 http://dx.doi.org/10.3390/jcm8101582

Ejemplares similares

Hemodynamic Effects of Sacubitril/Valsartan in Patients with Reduced Left Ventricular Ejection Fraction Over 24 Months: A Retrospective Study
por: Abumayyaleh, Mohammad, et al.
Publicado: (2022)

The impact of sacubitril/valsartan on outcome in patients suffering from heart failure with a concomitant diabetes mellitus
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2022)

Low Prevalence of Inappropriate Shocks in Patients With Inherited Arrhythmia Syndromes With the Subcutaneous Implantable Defibrillator Single Center Experience and Long‐Term Follow‐Up
por: Rudic, Boris, et al.
Publicado: (2017)

A narrative review on sacubitril/valsartan and ventricular arrhythmias
por: Wei, Zhaoyang, et al.
Publicado: (2022)

Clinical Outcomes in Patients with Ischemic versus Non-Ischemic Cardiomyopathy after Angiotensin-Neprilysin Inhibition Therapy
por: Abumayyaleh, Mohammad, et al.
Publicado: (2021)

Long-Term Follow-Up of Patients with Catecholaminergic Polymorphic Ventricular Arrhythmia
por: Veith, Michael, et al.
Publicado: (2020)

Simultaneous Non‐Invasive Epicardial and Endocardial Mapping in Patients With Brugada Syndrome: New Insights Into Arrhythmia Mechanisms
por: Rudic, Boris, et al.
Publicado: (2016)

Effect of sacubitril/valsartan on investigator‐reported ventricular arrhythmias in PARADIGM‐HF
por: Curtain, James P., et al.
Publicado: (2022)

Implantable cardioverter‐defibrillator in Brugada syndrome: Long‐term follow‐up
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2019)

Long‐term results of combined cardiac contractility modulation and subcutaneous defibrillator therapy in patients with heart failure and reduced ejection fraction
por: Röger, Susanne, et al.
Publicado: (2018)

Arrhythmic events in Brugada syndrome patients induced by fever
por: Roterberg, Gretje, et al.
Publicado: (2019)

Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting
por: Röger, Susanne, et al.
Publicado: (2018)

The Effect of Sacubitril-Valsartan on Ventricular Arrhythmia Burden in Patients With Heart Failure With Reduced Ejection Fraction
por: Medeiros, Paulo, et al.
Publicado: (2023)

Short‐term and long‐term incidence of stroke in Takotsubo syndrome
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2018)

Long‐Term Follow‐Up of Patients With Short QT Syndrome: Clinical Profile and Outcome
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2018)

The Wearable Cardioverter-Defibrillator: Experience in 153 Patients and a Long-Term Follow-Up
por: Rosenkaimer, Stephanie L., et al.
Publicado: (2020)

Pooled Analysis of Complications with Transvenous ICD Compared to Subcutaneous ICD in Patients with Catecholaminergic Polymorphic Ventricular Arrhythmia
por: Eckert, Henrik, et al.
Publicado: (2022)

Short- and Long-Term Incidence of Thromboembolic Events in Takotsubo Syndrome as Compared With Acute Coronary Syndrome
por: El-Battrawy, Ibrahim, et al.
Publicado: (2019)

Sex-differences in short QT syndrome: A systematic literature review and pooled analysis
por: El-Battrawy, Ibrahim, et al.
Publicado: (2019)

Combined implantation of dual-chamber ICD and optimizer through a persistent left superior vena cava
por: Fastenrath, Fabian, et al.
Publicado: (2016)

Sacubitril/valsartan in the treatment of systemic right ventricular failure
por: Zandstra, Tjitske E, et al.
Publicado: (2021)

Sacubitril/Valsartan Conundrum
por: Somberg, John
Publicado: (2021)

Impact of Antiarrhythmic Drugs on the Outcome of Short QT Syndrome
por: El-Battrawy, Ibrahim, et al.
Publicado: (2019)

Effect of sacubitril/valsartan or valsartan on ventricular remodeling and myocardial fibrosis in perimenopausal women with hypertension
por: Chen, Jianshu, et al.
Publicado: (2023)

Differences in Short QT Syndrome Subtypes: A Systematic Literature Review and Pooled Analysis
por: Raschwitz, Laura S., et al.
Publicado: (2020)

Septal myocardial scar burden predicts the response to cardiac contractility modulation in patients with heart failure
por: Ansari, Uzair, et al.
Publicado: (2022)

Exploration of Mechanisms of Sacubitril/Valsartan in the Treatment of Cardiac Arrhythmias Using a Network Pharmacology Approach
por: Zhou, Yu, et al.
Publicado: (2022)

Sacubitril/valsartan versus angiotensin inhibitors and arrhythmia endpoints in heart failure with reduced ejection fraction
por: Fernandes, Amanda D.F., et al.
Publicado: (2021)

Incidence and Prognostic Relevance of Cardiopulmonary Failure in Takotsubo Cardiomyopathy
por: El-Battrawy, Ibrahim, et al.
Publicado: (2017)

Implication of low dose sacubitril/valsartan
por: Imamura, Teruhiko
Publicado: (2021)

Eligibility and Usage of Sacubitril/Valsartan in Korea
por: Kim, Jin-Jin, et al.
Publicado: (2019)

Age related differences and outcome of patients with Takotsubo syndrome
por: Huseynov, Aydin, et al.
Publicado: (2017)

Effect of add-on sacubitril/valsartan on the left ventricular hypertrophy of a patient with hypertension
por: Imamura, Teruhiko, et al.
Publicado: (2022)

Prevalence, Clinical Characteristics, and Predictors of Patients with Thromboembolic Events in Takotsubo Cardiomyopathy
por: El-Battrawy, Ibrahim, et al.
Publicado: (2016)

Incidence, recurrence and management of electrical storm in Brugada syndrome
por: El-Battrawy, Ibrahim, et al.
Publicado: (2022)

Insights into implementation of sacubitril/valsartan into clinical practice
por: Martens, Pieter, et al.
Publicado: (2018)

Sacubitril–valsartan in heart failure and multimorbidity patients
por: Rodil Fraile, Raquel, et al.
Publicado: (2018)

Re: Implication of low‐dose sacubitril/valsartan
por: Pandey, Amitabh C., et al.
Publicado: (2021)

Molecular mechanisms of sacubitril/valsartan in cardiac remodeling
por: Mustafa, Nor Hidayah, et al.
Publicado: (2022)

Effects of Sacubitril/Valsartan on the Renal Resistance Index
por: Gioia, Margherita Ilaria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k4a5ig0n7kcrkjm9nhda30abkq